Stock Price
145.11
Daily Change
0.11 0.08%
Monthly
-20.67%
Yearly
-45.20%
Q1 Forecast
150.05

CSL reported $18M in Interest Income for its fiscal semester ending in December of 2024.





Interest Income Change Date
Arca Biopharma USD 4.09M 441K Mar/2025
aTyr Pharma USD 7.84K 3.09K Sep/2025
Bio Path USD 4K 0 Dec/2024
Cara Therapeutics USD 347K 74K Mar/2025
CSL USD 18M 1000K Dec/2024
Curis USD 806K 9K Sep/2023
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Immunic USD -0.24 0.03 Sep/2024